Mead Johnson Chief Financial Officer Peter G. Leemputte to Step Down
March 04 2015 - 4:53PM
Business Wire
Mead Johnson Nutrition Company (NYSE: MJN) announced today that
Peter G. Leemputte, its Executive Vice President and Chief
Financial Officer, has decided to leave the company for personal
reasons. Effective March 13, 2015, he will transition his
responsibilities to Charles Urbain. Mr. Urbain, currently Mead
Johnson’s Chief Development Officer, will serve as Interim CFO
until a permanent replacement is named. Mr. Leemputte will be
available to assist in the transition through June 30, 2015.
Mr. Leemputte, 57, has been with Mead Johnson since September
2008. He oversees the company’s accounting and reporting, financial
planning, audit, tax, treasury, investor relations and information
technology functions.
Kasper Jakobsen, President and Chief Executive Officer, said, “I
would like to thank Pete for his service to Mead Johnson. He has
made a significant contribution to our company during a period of
high growth, helping build our infrastructure to support our public
company status and leaving behind a strong team. He leaves the
company in a condition of great financial strength.”
“I’ve been honored to be part of the winning team at Mead
Johnson and to have contributed to our overall success during this
most recent period of the company’s long and proud history,” said
Mr. Leemputte. “After working for nearly 37 years, I intend to slow
down and spend more time with my family. I look forward to watching
the continued success of Mead Johnson.”
Mr. Urbain, 60, has been with the company for 28 years and has
held a variety of senior line management positions. Among other
roles, he has led the company’s business in each of its regions,
including Asia, and served as its Chief Financial Officer when Mead
Johnson was still a division of Bristol-Myers Squibb. As Chief
Development Officer, Mr. Urbain is currently responsible for key
administrative functions, including external business development,
corporate communications and human resources.
Mr. Urbain spent his early career with Price, Waterhouse &
Co. in London and subsequently held various positions in finance,
tax and treasury at Schlumberger Limited, before joining
Bristol-Myers Squibb. He has a Master’s Degree in Law from the
University of Witwatersrand in Johannesburg, South Africa, and
completed post graduate studies at Warwick University and the
London School of Economics in the United Kingdom.
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over
50 markets worldwide. The company’s mission is to nourish the
world’s children for the best start in life. The Mead Johnson name
has been associated with science-based pediatric nutrition products
for over 100 years. The company’s “Enfa” family of brands,
including Enfamil® infant formula, is the world’s leading brand
franchise in pediatric nutrition. For more information, visit
meadjohnson.com.
Mead Johnson Nutrition CompanyInvestors:Kathy MacDonald,
(847) 832-2182kathy.macdonald@mjn.comorMedia:Christopher
Perille, (847) 832-2178chris.perille@mjn.com
Morgan Stanley DW Str Sat Att (NYSE:MJN)
Historical Stock Chart
From Apr 2024 to May 2024
Morgan Stanley DW Str Sat Att (NYSE:MJN)
Historical Stock Chart
From May 2023 to May 2024